First Bank & Trust lowered its position in Varian Medical Systems, Inc. (NYSE:VAR) by 0.8% during the second quarter, Holdings Channel reports. The firm owned 2,109 shares of the medical equipment provider’s stock after selling 17 shares during the period. First Bank & Trust’s holdings in Varian Medical Systems were worth $217,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in VAR. Vanguard Group Inc. raised its position in shares of Varian Medical Systems by 3.3% in the first quarter. Vanguard Group Inc. now owns 9,007,195 shares of the medical equipment provider’s stock worth $820,826,000 after buying an additional 286,939 shares during the period. BlackRock Inc. raised its position in shares of Varian Medical Systems by 3,169.5% in the first quarter. BlackRock Inc. now owns 7,899,768 shares of the medical equipment provider’s stock worth $719,907,000 after buying an additional 7,658,148 shares during the period. First Eagle Investment Management LLC raised its position in shares of Varian Medical Systems by 7.5% in the first quarter. First Eagle Investment Management LLC now owns 4,641,466 shares of the medical equipment provider’s stock worth $422,977,000 after buying an additional 323,406 shares during the period. State Street Corp raised its position in shares of Varian Medical Systems by 1.3% in the first quarter. State Street Corp now owns 4,324,762 shares of the medical equipment provider’s stock worth $394,109,000 after buying an additional 57,090 shares during the period. Finally, Janus Capital Management LLC raised its position in shares of Varian Medical Systems by 8.5% in the first quarter. Janus Capital Management LLC now owns 3,932,124 shares of the medical equipment provider’s stock worth $358,332,000 after buying an additional 306,975 shares during the period. Institutional investors and hedge funds own 99.27% of the company’s stock.

Varian Medical Systems, Inc. (NYSE VAR) opened at 96.61 on Monday. The stock has a market capitalization of $8.86 billion, a price-to-earnings ratio of 31.80 and a beta of 0.61. The company has a 50-day moving average of $103.21 and a 200-day moving average of $92.66. Varian Medical Systems, Inc. has a 52-week low of $75.20 and a 52-week high of $107.08.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. During the same period in the prior year, the business earned $1.00 EPS. The firm’s revenue was up 3.0% on a year-over-year basis. Equities research analysts expect that Varian Medical Systems, Inc. will post $3.94 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “First Bank & Trust Reduces Stake in Varian Medical Systems, Inc. (NYSE:VAR)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/07/first-bank-trust-reduces-stake-in-varian-medical-systems-inc-nysevar.html.

VAR has been the topic of a number of research reports. BTIG Research upgraded shares of Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 target price on the stock in a research report on Monday, May 8th. BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 29th. Citigroup Inc. upgraded shares of Varian Medical Systems from a “neutral” rating to a “buy” rating in a research report on Monday, May 15th. Aegis reiterated a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research report on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) started coverage on shares of Varian Medical Systems in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective on the stock. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $96.28.

In other news, insider Dow R. Wilson sold 15,060 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $103.37, for a total value of $1,556,752.20. Following the completion of the transaction, the insider now owns 81,836 shares of the company’s stock, valued at $8,459,387.32. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP John W. Kuo sold 1,597 shares of the stock in a transaction on Thursday, July 13th. The stock was sold at an average price of $104.43, for a total value of $166,774.71. Following the completion of the transaction, the senior vice president now directly owns 28,224 shares of the company’s stock, valued at approximately $2,947,432.32. The disclosure for this sale can be found here. In the last three months, insiders sold 144,087 shares of company stock valued at $14,652,328. Company insiders own 0.91% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.